PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
24811969-6	2014	In contrast, three-factor PCC reversed rivaroxaban-induced changes in thrombin generation more than four-factor PCC.	Rivaroxaban	39-50	crystallin gamma D	Homo sapiens	26-29	
25136597-10	2014	Based on human clinical trial evidence, the 4-factor PCC (Kcentra) is suggested for patients with refractory rivaroxaban- or apixaban-associated hemorrhage.	Rivaroxaban	109-120	crystallin gamma D	Homo sapiens	53-56	
34837144-0	2021	Comparison of 4-factor PCC reversal of apixaban and rivaroxaban versus warfarin for intracranial hemorrhage.	Rivaroxaban	52-63	crystallin gamma D	Homo sapiens	23-26	
33609094-3	2021	RESULTS: 4F-PCC was ordered for 427 patients with warfarin-, apixaban-, or rivaroxaban-associated hemorrhage.	Rivaroxaban	75-86	crystallin gamma D	Homo sapiens	12-15